MetaCap

Enovis (ENOV) vs Materion (MTRN)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Materion (MTRN) has outperformed Enovis (ENOV) over the past year, gaining 55.3% versus a loss of 11.5%. Over five years, MTRN leads with a +108.4% price change compared with -69.5% for ENOV. Materion is the larger company by market cap ($3.81 billion vs $1.47 billion), about 2.6 times the size, while Enovis is growing revenue faster (+6.7% vs +6.0%).

On valuation, Enovis trades at a lower forward P/E (7.4x vs 20.7x for Materion). Materion pays a dividend yielding 0.31%, while Enovis does not currently pay one. Materion converts more of its revenue into profit, with a net margin of 4.2% versus -52.7%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

ENOV-11.47%MTRN+55.33%
+182%+66%-50%
Nov 21, 20251 yearNov 20, 2026
ENOV-70.68%MTRN+97.29%
+253%+79%-95%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

ENOV versus MTRN key metrics
MetricENOVMTRN
Share price$25.47$182.47
Market cap$1.47B$3.81B
1-day change-2.90%-10.02%
YTD return-4.39%+46.77%
1-year return-11.47%+55.33%
5-year return-69.49%+108.37%
P/E ratio (TTM)—37.39
Forward P/E7.3520.72
EPS (TTM)$-9.23$4.88
Dividend yield0.00%0.31%
Annual dividend$0.00$0.57
Revenue (latest FY)$2.25B$1.79B
Revenue growth (YoY)+6.66%+6.04%
Net income (latest FY)$-1.18B$74.82M
Gross margin59.84%17.27%
Operating margin-50.01%6.15%
Net margin-52.69%4.19%
52-week high$31.67$324.99
52-week low$16.70$116.02
Distance from 52-week high-19.58%-43.85%
Analyst consensusstrong_buynone
Avg. price target upside+48.53%+44.96%
Average volume1.71M248.26K
Shares outstanding57.69M20.86M
Employees7,8023,000
SectorHealth CareIndustrials
IndustryIndustrial SpecialtiesIndustrial Specialties

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • Materion is about 2.6 times larger than Enovis by market value ($3.81B vs $1.47B).
  • MTRN has outperformed ENOV by 66.8 percentage points over the past year.
  • Materion is more profitable, keeping 4.2 cents of every revenue dollar as net income versus -52.7 cents for Enovis.
  • The two companies sit in different sectors: Enovis in Health Care and Materion in Industrials.

About Enovis

ENOV stock →

Enovis Corporation, a medical technology company, focuses on developing clinically differentiated solutions in the United States and internationally. It operates through two segments: Prevention and Recovery, and Reconstructive segments.

Health Care · Industrial Specialties · 7,802 employees

About Materion

MTRN stock →

Materion Corporation, together with its subsidiaries, produces advanced engineered materials in the United States, Asia, Europe, and internationally. The company operates in four segments: Performance Materials, Electronic Materials, Precision Optics, and Other.

Industrials · Industrial Specialties · 3,000 employees

ENOV vs MTRN FAQ

Which is bigger, Enovis or Materion?

Materion (MTRN) is larger, with a market capitalization of $3.81B compared with $1.47B for Enovis (ENOV).

Which stock has performed better over the past year, ENOV or MTRN?

MTRN returned +55.33% over the past 12 months, compared with -11.47% for ENOV (price return, excluding dividends). Past performance does not predict future results.

Which pays a higher dividend, Enovis or Materion?

Materion pays a dividend yielding 0.31%, while Enovis does not currently pay a regular dividend.

Are Enovis and Materion in the same industry?

Yes. Both are classified in the Industrial Specialties industry within the Health Care sector.

More comparisons